[Clinical findings during treatment with a new derivative of plant auxins with a phenoxyacetic structure (Thymodin or ANP 297)].
D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy*; D006801:Humans; D007454:Iodides / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use; D010937:Plant Growth Regulators; D013943:Thymol / Q000627:therapeutic use*
D000928:Antidepressive Agents; D007454:Iodides; D010936:Plant Extracts; D010937:Plant Growth Regulators; D013943:Thymol
Rilievi clinic in corso di trattamento con un nuovo derivato delle auxine vegetali a struttura fenossiacetica (Timodine o ANP 297)